She concentrates on early detection and prevention methods for people at higher threat for ovarian and uterine cancers and HPV-similar conditions. She is actively associated with medical and translational research analyzing gynecologic cancer outcomes through clinical demo enhancement with an emphasis on healthcare disparities. Type 1 endometrial cancers are significantly https://kylerqpkex.mpeblog.com/69830693/the-2-minute-rule-for-how-i-knew-i-had-uterine-cancer